Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy

NCT: NCT05095051 · COMPLETED

NCT IDNCT05095051
StatusCOMPLETED
Start Date2021-11-03
Completion2023-07-05
SponsorNational University Hospital, Singapore (OTHER)
First posted
Last updated

Brief Summary

The study aims to investigate the safety and tolerability of limb cryocompression in preventing of Chemotherapy-induced Peripheral Neuropathy via a newly developed limb cryocompression device in healthy subjects and cancer patients. The limb cryocompression device will be tested for its safety in delivering limb cryocompression and efficacy in improving the preservation of peripheral nerves during chemotherapy.

Frequently Asked Questions

What is A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy?

A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy is a clinical trial registered under NCT05095051. Current status: COMPLETED.

What is the status of NCT05095051?

The current status of NCT05095051 (A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy) is: COMPLETED.

When did A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy start?

A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy started on 2021-11-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑